Skip to main content
OpenTrials

Clinical trial condition

HIV-1 Infection

Explore clinical trials studying HIV-1 Infection. Study availability and eligibility vary by location and protocol.

182 public trials 1 recruiting study
Refine in advanced search Browse all conditions

HIV-1 Infection trial results

Completed

FTC/RPV/TDF on T-Cell Activation, CD4+ T-Cell Count, Inflammatory Biomarkers and Viral Reservoir

NCT01777997

Conditions
HIV-1 Infection
Locations
  • 31788 Alabama CRS Birmingham, Alabama, United States
  • 801 University of California, San Francisco HIV/AIDS CRS San Francisco, California, United States
  • Whitman Walker Health CRS (31791) Washington D.C., District of Columbia, United States
  • The Ponce de Leon Ctr. CRS (5802) Atlanta, Georgia, United States
View all 19 locations
View Trial Details
Completed

Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells

NCT01351025

Conditions
HIV-1 Infection
Locations
  • 31788 Alabama CRS Birmingham, Alabama, United States
  • UCLA CARE Center CRS (601) Los Angeles, California, United States
  • Ucsd, Avrc Crs (701) San Diego, California, United States
  • Harbor-UCLA Med. Ctr. CRS (603) Torrance, California, United States
View all 31 locations
View Trial Details
Completed

Telmisartan to Reduce AIDS-Related Fibrotic and Inflammatory Contributors (TRAFIC Study)

NCT01928927

Conditions
HIV-1 Infection
Locations
  • UCLA CARE Center CRS (601) Los Angeles, California, United States
  • University of Colorado Hospital CRS (6101) Aurora, Colorado, United States
  • Massachusetts General Hospital ACTG CRS (101) Boston, Massachusetts, United States
  • Washington U CRS (2101) St Louis, Missouri, United States
View Trial Details
Completed

Study to Evaluate the Safety and Efficacy of Vesatolimod in Antiretroviral Treated Human Immunodeficiency Virus (HIV-1) Infected Controllers

NCT03060447

Conditions
HIV-1 Infection
Locations
  • Mills Clinical Research Los Angeles, California, United States
  • Zuckerberg San Francisco General San Francisco, California, United States
  • Midway Immunology & Research Center Ft. Pierce, Florida, United States
  • Orlando Immunology Center Orlando, Florida, United States
View Trial Details
Completed

Study to Evaluate Safety, Pharmacokinetics, and Antiviral Activity of Lenacapavir Administered Subcutaneously in Human Immunodeficiency Virus (HIV) -1 Infected Adults

NCT03739866

Conditions
HIV-1 Infection
Locations
  • Ruane Clinical Research Group, Inc. Los Angeles, California, United States
  • Mills Clinical Research Los Angeles, California, United States
  • One Community Sacramento, California, United States
  • The Lundquist Institute for BioMedical Innovation at Harbor-UCLA Medical Center Torrance, California, United States
View Trial Details
Completed

Study to Evaluate the Safety and Efficacy of Switching From Regimens Consisting of Boosted Atazanavir or Darunavir Plus Either Emtricitabine/Tenofovir or Abacavir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed HIV-1 Infected Adults

NCT02603107

Conditions
HIV-1 Infection
Locations
  • Phoenix, Arizona, United States
  • Phoenix, Arizona, United States
  • Los Angeles, California, United States
  • Los Angeles, California, United States
View all 119 locations
View Trial Details

Related conditions